Oramed Pharma (ORMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 08-2015 | 08-2014 | 08-2013 | 12-2012 | 08-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,232 | -5,696 | -4,232 | N/A | -3,344 |
| Depreciation Amortization | 4 | 6 | 5 | N/A | 15 |
| Other Working Capital | 862 | 161 | -353 | N/A | 260 |
| Other Operating Activity | 1,420 | 1,461 | 1,184 | 0 | 768 |
| Operating Cash Flow | $-4,946 | $-4,068 | $-3,396 | $N/A | $-2,301 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,143 | -6,574 | -4,566 | N/A | 1,775 |
| PPE Investments | -1 | -14 | -6 | N/A | -2 |
| Purchase Of Investment | -17,452 | -6,500 | N/A | N/A | N/A |
| Other Investing Activity | -2 | 0 | 3 | 0 | -4 |
| Investing Cash Flow | $-3,312 | $-13,088 | $-4,569 | $N/A | $1,769 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,721 | 16,640 | 5,824 | N/A | 3,489 |
| Financing Cash Flow | $9,721 | $16,640 | $5,824 | $N/A | $3,489 |
| Exchange Rate Effect | -12 | 6 | -18 | N/A | -39 |
| Beginning Cash Position | 1,762 | 2,272 | 4,431 | N/A | 1,513 |
| End Cash Position | 3,213 | 1,762 | 2,272 | N/A | 4,431 |
| Net Cash Flow | $1,451 | $-510 | $-2,159 | $N/A | $2,918 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,946 | -4,068 | -3,396 | N/A | -2,301 |
| Capital Expenditure | -1 | -14 | -6 | N/A | -2 |
| Free Cash Flow | -4,947 | -4,082 | -3,402 | 0 | -2,303 |